Posted by Joseph Griffin on Apr 26th, 2024
Molina Healthcare (NYSE:MOH – Free Report) had its target price decreased by Barclays from $437.00 to $430.00 in a research note published on Thursday morning, Benzinga reports. Barclays currently has an equal weight rating on...
More of this article »